Levobupivacaine Altan (Levobupivacaine)

Levobupivacaine is a local anesthetic administered via the epidural route to achieve regional nerve blockade.

• Surgical procedures: provides epidural anesthesia for intra‑operative pain control during various operations.
• Labor analgesia: offers effective pain relief throughout childbirth while preserving maternal consciousness.
• Post‑operative pain management: maintains analgesia after surgery to reduce the need for systemic opioids.

• Levobupivacaine exerts its anesthetic effect by reversibly binding to the intracellular portion of voltage‑gated sodium channels on neuronal membranes. This binding stabilizes the channel in an inactive state, preventing the influx of sodium ions during depolarization. As a result, the generation and propagation of nerve impulses are blocked, producing loss of sensation in the targeted region without affecting consciousness.

Levobupivacaine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Hypotension: transient drop in blood pressure after epidural administration.
• Bradycardia: slowed heart rate that may require monitoring.
• Nausea: occasional feeling of sickness post‑procedure.
• Pruritus: mild itching, often at the injection site.
• Urinary retention: difficulty voiding that resolves after catheter removal.
• Vomiting: occasional emesis following the block.

Serious or Rare Side Effects

• Cardiac arrhythmia: irregular heart rhythm that can be life‑threatening.
• Seizures: central nervous system excitation in overdose situations.
• Respiratory depression: reduced breathing effort requiring support.
• Anaphylactic reaction: severe allergic response with hives, swelling, and airway compromise.
• Spinal hematoma: bleeding in the epidural space that may compress nerves.
• Permanent nerve injury: rare but possible lasting sensory or motor deficits.

Prior to using Levobupivacaine, clinicians should consider several safety measures.

• Cardiovascular assessment: evaluate heart rate and blood pressure before administration.
• Dose adjustment in the elderly or hepatic impairment: consider reduced dose.
• Concurrent CNS depressants: use with caution due to additive effects.
• Allergy history: avoid in patients with known hypersensitivity to amide local anesthetics.
• Pregnancy considerations: use only when benefit outweighs potential risk, as safety data are limited.
• Store at ambient temperature: keep in original container, protect from light and moisture.

Levobupivacaine can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

• Class I antiarrhythmics (e.g., quinidine): may increase cardiotoxicity.
• Beta‑blockers: can potentiate bradycardia and hypotension.
• General anesthetics (e.g., propofol): additive CNS depression.

Moderate Interactions (Monitor Closely)

• Epidural opioids: may enhance respiratory depression.
• NSAIDs: may increase bleeding risk when combined with anticoagulants.
• Magnesium sulfate: may potentiate neuromuscular blockade.